Nuvation Bio, Inc. (NUVB)
4.45
-0.30
(-6.32%)
USD |
NYSE |
Oct 16, 16:00
4.46
+0.01
(+0.22%)
After-Hours: 20:00
Nuvation Bio Free Cash Flow : -128.92M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -128.92M |
| March 31, 2026 | -134.06M |
| December 31, 2025 | -181.78M |
| September 30, 2025 | -198.25M |
| June 30, 2025 | -168.58M |
| March 31, 2025 | -157.54M |
| December 31, 2024 | -130.58M |
| September 30, 2024 | -99.33M |
| June 30, 2024 | -84.27M |
| March 31, 2024 | -64.46M |
| December 31, 2023 | -68.07M |
| September 30, 2023 | -69.26M |
| Date | Value |
|---|---|
| June 30, 2023 | -81.28M |
| March 31, 2023 | -90.88M |
| December 31, 2022 | -96.48M |
| September 30, 2022 | -103.86M |
| June 30, 2022 | -88.84M |
| March 31, 2022 | -78.56M |
| December 31, 2021 | -68.47M |
| September 30, 2021 | -57.82M |
| June 30, 2021 | -52.70M |
| March 31, 2021 | -42.70M |
| December 31, 2020 | -36.67M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol Myers Squibb Co. | 11.44B |
| Johnson & Johnson | 22.61B |
| Pfizer Inc. | 10.99B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -42.97M |
| Cash from Investing (Quarterly) | 5.991M |
| Cash from Financing (Quarterly) | 170.53M |
| Free Cash Flow Per Share (Quarterly) | -0.1239 |
| Free Cash Flow to Equity (Quarterly) | -242.50M |
| Free Cash Flow to Firm (Quarterly) | -36.46M |
| Free Cash Flow Yield | -8.20% |